Business Context and Reporting Period
Company: Alto Ingredients, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2026
Event: Entry into a Material Definitive Agreement (At-The-Market Issuance Sales Agreement).
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It discloses the following capital market parameters:
- Maximum Offering Size: Up to $50.0 million in aggregate offering price.
- Security Type: Common Stock, $0.001 par value per share.
- Commission Fee: 3.0% of aggregate gross proceeds paid to agents.
- Intended Use of Proceeds: General corporate purposes, including working capital and capital expenditures.
Material Changes
The Company entered into a Sales Agreement with Craig-Hallum Capital Group LLC (Designated Agent), The Benchmark Company, LLC, and H.C. Wainwright & Co., LLC (Agents). This agreement allows the Company to offer and sell shares through "at-the-market" offerings. No shares have been sold as of the filing date; the agreement provides the mechanism for future sales.
Guidance, Outlook, and Risks
- Outlook: The Company is not obligated to sell any shares. There is no assurance that any shares will be sold, nor regarding the price, amount, or timing of potential sales.
- Termination: The offering terminates upon the sale of all shares or earlier termination of the agreement.
- Risks: The filing explicitly states it is not an offer to sell securities and directs investors to other public filings for factual information regarding the Company's current state of affairs.
Investor Verification Checklist
- Verify the current market price of ALTO stock to assess potential dilution impact.
- Review the effective shelf registration statement (Form S-3 No. 333-295723) filed on May 8, 2026.
- Monitor future filings for actual share sales and proceeds generated under this agreement.
- Check the Company's most recent 10-K or 10-Q for current liquidity and working capital needs.